Integra Launches New Product - Analyst Blog
Integra LifeSciences Holdings Corp. (IART) recently launched a new product in the U.S., Integra Total Wrist Fusion System, a solution for wrist arthrodesis that is designed to provide fixation of the wrist while decreasing soft tissue irritation. The product uses the Surfix locking and dynamic compression technologies to provide an optimal balance of compression and stability.
The new product expands Integra’s portfolio of upper extremity products. Integra Total Wrist Fusion System addresses severe wrist arthritis, which includes the Universal2 Total Wrist Implant System.
We believe that as a result of enhanced features the new product will be widely accepted by surgeons. This will cater to the company’s overall top-line growth.
Integra is a global leader in regenerative medicine. The company’s products are dedicated to improving the quality of life for millions of patients. Integra’s products are primarily used in orthopedic, general surgery and neurosurgery.
Integra's Extremity Reconstruction sales organization will market the Integra Total Wrist Fusion System. The division markets lower extremity reconstruction, upper extremity reconstruction, tendon protection/augmentation, peripheral nerve repair/protection, and wound repair products across the globe.
Integra faces tough competition across its different segments. In neurosurgery, its main competitors are Medtronic Inc. (MDT), Johnson & Johnson (JNJ) and B. Braun. In the reconstructive surgery segment, Integra competes with Wright Medical Group, Inc. (WMGI). The orthopedic segment witnesses competition from Johnson & Johnson, Wright Medical and Stryker Corp. (SYK).
Read the full analyst report on "IART"
Read the full analyst report on "MDT"
Read the full analyst report on "JNJ"
Read the full analyst report on "WMGI"
Read the full analyst report on "SYK"
Zacks Investment Research
